The Master in Fine Arts program, based at our New York City campus, has for the past fifteen years welcomed practitioners from diverse backgrounds and career stages to reflect on and expand their ...
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...
Barclay Palmer is a creative executive with 10+ years of creating or managing premium programming and brands/businesses across various platforms. Gordon Scott has been an active investor and technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback